$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

$lsta Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000032001717000093 Filed on November 09, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$1.900M	$0.00	$9.317M
YoY Change		-100.0%	58.23%
Cost Of Revenue			$8.611M
YoY Change			79.08%
Gross Profit			$706.3K
YoY Change			-34.59%
Gross Profit Margin			7.58%
Selling, General & Admin	$2.670M	$2.943M	$2.769M
YoY Change	16.59%	6.28%	-46.2%
% of Gross Profit			392.05%
Research & Development	$4.650M	$3.187M	$2.959M
YoY Change	45.31%	7.72%	-53.15%
% of Gross Profit			418.91%
Depreciation & Amortization	$90.00K	$90.00K	$100.0K
YoY Change	-10.0%	-10.0%	-84.37%
% of Gross Profit			14.16%
Operating Expenses	$7.320M	$6.130M	$5.728M
YoY Change	33.33%	7.03%	-64.8%
Operating Profit		-$6.130M	-$5.728M
YoY Change		7.03%	-44.84%
Interest Expense	-$10.00K	$8.687K	$368.4K
YoY Change	-94.44%	-97.64%	-33.39%
% of Operating Profit
Other Income/Expense, Net	$140.0K	$168.2K	-$363.2K
YoY Change		-146.3%	-62.29%
Pretax Income	-$7.190M	-$5.962M	-$6.091M
YoY Change	26.81%	-2.12%	-46.32%
Income Tax	-$3.230M	-$2.414M	$0.00
% Of Pretax Income
Net Earnings	-$2.860M	-$3.548M	-$7.288M
YoY Change	-52.01%	-51.32%	63961.23%
Net Earnings / Revenue	-150.53%		-78.21%
Basic Earnings Per Share
Diluted Earnings Per Share	-$302.3K	-$377.3K	-$1.089M
COMMON SHARES
Basic Shares Outstanding	9.471M shares	8.913M shares	5.914M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$55.08M	$59.45M	$18.60M
YoY Change	678.33%	219.62%	-36.72%
Cash & Equivalents	$29.16M	$15.08M	$18.61M
Short-Term Investments	$25.92M	$44.37M
Other Short-Term Assets	$6.300M	$5.900M	$7.100M
YoY Change	-63.79%	-16.9%	5.97%
Inventory
Prepaid Expenses
Receivables	$234.5K	$401.6K	$4.275M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$61.40M	$65.77M	$29.96M
YoY Change	149.09%	119.5%	-22.13%
LONG-TERM ASSETS
Property, Plant & Equipment	$257.0K	$364.1K	$17.12M
YoY Change	-63.57%	-97.87%	0.17%
Goodwill			$7.013M
YoY Change			-72.18%
Intangibles			$2.450M
YoY Change			-93.5%
Long-Term Investments
YoY Change
Other Assets	$1.722M	$1.417M	$726.8K
YoY Change	8.84%	95.03%	-39.92%
Total Long-Term Assets	$1.979M	$1.782M	$27.31M
YoY Change	-93.14%	-93.48%	-66.37%
TOTAL ASSETS
Total Short-Term Assets	$61.40M	$65.77M	$29.96M
Total Long-Term Assets	$1.979M	$1.782M	$27.31M
Total Assets	$63.38M	$67.56M	$57.28M
YoY Change	18.43%	17.94%	-52.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.343M	$879.6K	$3.246M
YoY Change	-39.68%	-72.9%	31.57%
Accrued Expenses	$7.812M	$10.14M	$6.373M
YoY Change	193.75%	59.04%	-20.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$2.320M
YoY Change	-100.0%	-100.0%	-15.69%
Total Short-Term Liabilities	$9.314M	$11.37M	$18.55M
YoY Change	-56.03%	-38.69%	-6.01%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$3.332M
YoY Change	-100.0%	-100.0%	-72.8%
Other Long-Term Liabilities	$3.873M	$3.200M	$370.1K
YoY Change	893.44%	764.72%	-89.3%
Total Long-Term Liabilities	$3.873M	$3.200M	$3.702M
YoY Change	-86.35%	-13.55%	-76.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.314M	$11.37M	$18.55M
Total Long-Term Liabilities	$3.873M	$3.200M	$3.702M
Total Liabilities	$13.19M	$14.57M	$27.89M
YoY Change	-56.11%	-47.74%	-56.9%
SHAREHOLDERS EQUITY
Retained Earnings	-$381.8M	-$378.9M	-$398.8M
YoY Change	-5.68%	-4.99%	17.67%
Common Stock	$9.000K	$9.427K	$8.182K
YoY Change	9.68%	15.22%	-85.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$708.0K	$707.6K	$707.6K
YoY Change	0.05%	0.0%	0.27%
Treasury Stock Shares	11.08K shares	11.08K shares	11.00K shares
Shareholders Equity	$50.51M	$53.33M	$10.75M
YoY Change
Total Liabilities & Shareholders Equity	$63.38M	$67.56M	$57.28M
YoY Change	18.43%	17.94%	-52.15%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$2.860M	-$3.548M	-$7.288M
YoY Change	-52.01%	-51.32%	63961.23%
Depreciation, Depletion And Amortization	$90.00K	$90.00K	$100.0K
YoY Change	-10.0%	-10.0%	-84.37%
Cash From Operating Activities	-$3.970M	-$6.330M	-$5.710M
YoY Change	17.46%	10.86%	-34.37%
INVESTING ACTIVITIES
Capital Expenditures	-$20.00K	-$20.00K	$0.00
YoY Change	-33.33%		-100.0%
Acquisitions
YoY Change
Other Investing Activities	$18.26M	-$3.780M	-$610.0K
YoY Change	-3752.0%	519.67%	-74.48%
Cash From Investing Activities	$18.23M	-$3.790M	-$620.0K
YoY Change	-3539.62%	511.29%	-80.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-180.0K	2.160M	7.240M
YoY Change		-70.17%	-2435.48%
NET CHANGE
Cash From Operating Activities	-3.970M	-6.330M	-5.710M
Cash From Investing Activities	18.23M	-3.790M	-620.0K
Cash From Financing Activities	-180.0K	2.160M	7.240M
Net Change In Cash	14.08M	-7.960M	910.0K
YoY Change	-460.1%	-974.73%	-107.48%
FREE CASH FLOW
Cash From Operating Activities	-$3.970M	-$6.330M	-$5.710M
Capital Expenditures	-$20.00K	-$20.00K	$0.00
Free Cash Flow	-$3.950M	-$6.310M	-$5.710M
YoY Change	17.91%	10.51%	-27.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2017Q3	clbs	Aggregate Intrinsic Value Warrants Outstanding AggregateIntrinsicValueWarrantsOutstanding	0	USD
CY2017Q3	clbs	Aggregate Intrinsic Value Warrantsvested AggregateIntrinsicValueWarrantsvested	0	USD
CY2017Q3	clbs	Aggregate Intrinsic Value Warrantsvestedandexpectedtovest AggregateIntrinsicValueWarrantsvestedandexpectedtovest	0	USD
	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
	clbs	Changein Ownershipin Subsidiary ChangeinOwnershipinSubsidiary	0	USD
CY2016Q4	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	388062	shares
CY2017Q3	clbs	Common Stock Warrants Shares CommonStockWarrantsShares	218978	shares
	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-3210626	USD
	clbs	Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities	-5823272	USD
CY2016Q4	clbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2017Q3	clbs	Preferred Stock Shares Designated PreferredStockSharesDesignated	825000	shares
CY2017Q3	clbs	Sharesvestedandexpectedtovest Sharesvestedandexpectedtovest	218978	shares
	clbs	Warrants Canceled WarrantsCanceled	1691	shares
	clbs	Warrants Exercised WarrantsExercised	0	shares
	clbs	Warrants Expired WarrantsExpired	167393	shares
	clbs	Warrants Granted WarrantsGranted	0	shares
CY2017Q3	clbs	Warrants Vested WarrantsVested	218978	shares
	clbs	Weighted Average Exercise Price Warrants Canceled WeightedAverageExercisePriceWarrantsCanceled	700.00
CY2017Q3	clbs	Weighted Average Exercise Price Warrants Exercisable WeightedAverageExercisePriceWarrantsExercisable	54.80
	clbs	Weighted Average Exercise Price Warrants Exercised WeightedAverageExercisePriceWarrantsExercised	0.00
	clbs	Weighted Average Exercise Price Warrants Expired WeightedAverageExercisePriceWarrantsExpired	104.50
	clbs	Weighted Average Exercise Price Warrants Granted WeightedAverageExercisePriceWarrantsGranted	0.00
CY2016Q4	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	76.50
CY2017Q3	clbs	Weighted Average Exercise Price Warrants Outstanding WeightedAverageExercisePriceWarrantsOutstanding	54.80
CY2017Q3	clbs	Weighted Average Exercise Price Warrantsvestedexpectedtovest WeightedAverageExercisePriceWarrantsvestedexpectedtovest	54.80
	clbs	Weighted Average Remaining Contractual Term Warrants Vestedand Expectto Vest WeightedAverageRemainingContractualTermWarrantsVestedandExpecttoVest	P1Y1M24D
CY2016	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P1Y2M27D
	clbs	Weighted Average Remaining Contractual Termwarrantoutstanding WeightedAverageRemainingContractualTermwarrantoutstanding	P1Y1M24D
	clbs	Weighted Average Remaining Contractual Termwarrantsvested WeightedAverageRemainingContractualTermwarrantsvested	P1Y1M24D
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9470860	shares
	dei	Entity Central Index Key EntityCentralIndexKey	0000320017
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Entity Registrant Name EntityRegistrantName	Caladrius Biosciences, Inc.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2226580	USD
CY2017Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2017Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	56273200	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	100	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	28800	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	879625	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138774	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	401558	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-218755	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2659433	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10135600	USD
CY2016Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	2659400	USD
CY2017Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	10135700	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	224500	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	367300	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-28717	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	410372049	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	433006780	USD
CY2016Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1040600	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2275600	USD
CY2017Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62400	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2770700	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2016Q4	us-gaap	Assets Assets	53514442	USD
CY2017Q3	us-gaap	Assets Assets	67555259	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	24648961	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	65773702	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	15533043	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	4426800	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	56273200	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearAmortizedCostBasis	56273200	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	56244500	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	0	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	4426800	USD
CY2017Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	56244500	USD
CY2016Q4	us-gaap	Cash Cash	4426800	USD
CY2017Q3	us-gaap	Cash Cash	11872900	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7076651	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15077872	USD
CY2016Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	4426800	USD
CY2017Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	56244500	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18657971	USD
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11644065	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7076651	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20080521	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	1660440	USD
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	6962677	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	7628357	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	0	USD
CY2016Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	18606742	USD
CY2017Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20080521	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1711669	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5375513	USD
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	0	USD
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	6727263	USD
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	3941244	USD
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-74231	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1247623	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-188794	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	2608615	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-638069	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8205791	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9427001	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8205791	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9427001	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	8206	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	9427	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6883019	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26698652	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3457157	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	25812849	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-405072	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-522005	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-119342	USD
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-717665	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-7288091	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27220657	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3576499	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	25095184	USD
CY2016Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1	shares
CY2017Q3	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	1	shares
CY2016Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	0	USD
CY2017Q3	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1745500	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	19400000	USD
CY2017Q3	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	700000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1100000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	351226	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	284005	USD
CY2016Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	26577834	USD
CY2017Q3	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	0	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1681594	USD
CY2017Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.09
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-4.45
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.38
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	2.94
CY2016Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1406300	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1169600	USD
CY2016Q1	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.199
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	591307	USD
	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	175793	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6031344	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-25404351	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3428440	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12056553	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-59423	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-187126	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-119342	USD
	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-149509	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6090767	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25591477	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5961733	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-20507556	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-6090767	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-25591477	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3547782	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-12206062	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.95
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-4.23
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.38
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-1.37
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1196838	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1628694	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	37329963	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-345649	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-334879	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-568156	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-851189	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1293815	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	37898119	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.13
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.22
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	4.30
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2413951	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8301494	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-14424	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	262784	USD
	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	-1605550	USD
	us-gaap	Increase Decrease In Due From Affiliates Current IncreaseDecreaseInDueFromAffiliatesCurrent	1681593	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-191717	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-164788	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-871417	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-980495	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	368364	USD
	us-gaap	Interest Expense InterestExpense	1601421	USD
CY2017Q3	us-gaap	Interest Expense InterestExpense	8687	USD
	us-gaap	Interest Expense InterestExpense	372099	USD
	us-gaap	Interest Paid InterestPaid	973729	USD
	us-gaap	Interest Paid InterestPaid	706231	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2275616	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1881712	USD
CY2016Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1000000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	300000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1100000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	30047962	USD
CY2017Q3	us-gaap	Liabilities Liabilities	14574932	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	53514442	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67555259	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	21182893	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	11374778	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	10925052	USD
CY2017Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2016Q4	us-gaap	Marketable Securities MarketableSecurities	0	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20292231	USD
CY2016Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	5791134	USD
CY2017Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3126457	USD
CY2017Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2524897	USD
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2016Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	159180	USD
CY2017Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	USD
CY2016Q4	us-gaap	Marketable Securities MarketableSecurities	0	USD
CY2017Q3	us-gaap	Marketable Securities MarketableSecurities	44372000	USD
CY2017Q3	us-gaap	Marketable Securities MarketableSecurities	44371615	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	-817429	USD
CY2017Q3	us-gaap	Minority Interest MinorityInterest	-352383	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20896315	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-754446	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16955071	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-680215	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2315753	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	23036191	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1068130	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	23224985	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16906232	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-22900846	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16268163	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6882533	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-26698166	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3428440	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	25841566	USD
CY2016Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-363247	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1581862	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	168168	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-234811	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	700000	USD
CY2017Q3	us-gaap	Notes Payable NotesPayable	400000	USD
CY2016Q4	us-gaap	Notes Payable Current NotesPayableCurrent	563777	USD
CY2017Q3	us-gaap	Notes Payable Current NotesPayableCurrent	359553	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	5727520	USD
	us-gaap	Operating Expenses OperatingExpenses	24009615	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	6129901	USD
	us-gaap	Operating Expenses OperatingExpenses	20272745	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5727520	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-24009615	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6129901	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20272745	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-28717	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1582209	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1417439	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3335700	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	603000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	801600	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	786200	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	817400	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	327500	USD
CY2016Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	232700000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	1028600	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	544700	USD
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-486	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-486	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-486	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-28717	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-28717	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-486	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-486	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-28717	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-28717	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	389858	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3200154	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5117	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19559	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	176855	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	137288	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	357665	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	51724691	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1068130	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	118478	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	10000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	10000	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	100	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1900493	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	920008	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	74689814	USD
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	15000000	USD
	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	11650712	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	5678632	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	368615	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	400998	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	7105603	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13576	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-7287605	USD
	us-gaap	Profit Loss ProfitLoss	-27220171	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-3547782	USD
	us-gaap	Profit Loss ProfitLoss	25123901	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2958593	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13496045	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3187024	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11190939	USD
CY2016Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	705438	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	364118	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	19400000	USD
CY2017Q3	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	9348646	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5651354	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	715610	USD
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	764402	USD
CY2017Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	5002649	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-404788809	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-378947243	USD
CY2016Q4	us-gaap	Retention Payable RetentionPayable	0	USD
CY2017Q3	us-gaap	Retention Payable RetentionPayable	2233000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2768927	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10513570	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2942877	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9081806	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1900000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	1900000	USD
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	300000	USD
CY2016Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	4.72
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	107719	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	132726	shares
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11650712	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5678632	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	651700	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	469900	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2275616	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2412981	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	13576	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4883909	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	53332710	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	23283824	USD
CY2016Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9989495	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4066480	USD
CY2017Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	52980327	USD
CY2016Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	USD
CY2017Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	4075600	USD
	us-gaap	Temporary Equity Elimination As Partof Reorganization TemporaryEquityEliminationAsPartofReorganization	3686526	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	11080	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6001572	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	9093880	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8803784	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	11080	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	707637	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	707637	USD
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6323427	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of Risks</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are subject to credit risk from our portfolio of cash, cash equivalents, restricted cash, and marketable securities. Under our investment policy, we limit amounts invested in such securities by credit rating, maturity, industry group, investment type and issuer, except for securities issued by the U.S. government. Cash is held at major banks in the United States. Therefore, the Company is not exposed to any significant concentrations of credit risk from these financial instruments. The goals of our investment policy, in order of priority, are as follows: safety and preservation of principal and diversification of risk, liquidity of investments sufficient to meet cash flow requirements, and a competitive after-tax rate of return.</font></div></div>

Files In Submission

Name	View Source	Status
0000320017-17-000093-index-headers.html	Edgar Link	pending
0000320017-17-000093-index.html	Edgar Link	pending
0000320017-17-000093.txt	Edgar Link	pending
0000320017-17-000093-xbrl.zip	Edgar Link	pending
clbs-10qx20170930.htm	Edgar Link	pending
clbs-20170930.xml	Edgar Link	completed
clbs-20170930.xsd	Edgar Link	pending
clbs-20170930_cal.xml	Edgar Link	unprocessable
clbs-20170930_def.xml	Edgar Link	unprocessable
clbs-20170930_lab.xml	Edgar Link	unprocessable
clbs-20170930_pre.xml	Edgar Link	unprocessable
clbs-ex311_20170930xq3.htm	Edgar Link	pending
clbs-ex312_20170930xq3.htm	Edgar Link	pending
clbs-ex321_20170930xq3.htm	Edgar Link	pending
clbs-ex322_20170930xq3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta

2017 Q4 Form 10-Q Financial Statement

#000032001717000093 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA LISATA THERAPEUTICS, INC. Stock $lsta

2017 Q4 Form 10-Q Financial Statement

#000032001717000093 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LSTA
LISATA THERAPEUTICS, INC. Stock $lsta